CRO Market Outlook: Growth Potential & Regulatory Obstacles
As per insights, the global clinical research organization (CRO) market is projected to achieve a value of $139.56 billion by 2033. The market is...
US – China Trade In Pharmaceuticals Soars In Recent Years
The US-China trade in pharmaceuticals has shifted due to the trade war and the pandemic. While some sectors have seen a decline, pharmaceutical trade...
Biotech M&A Is Set For Rebound With Billion-Dollar Deals
2022 was an unremarkable year for biotech mergers and acquisitions (M&A) as the industry experienced a decline in both the number and value of...
Centogene, Lifera Join Forces To Improve Multiomic Testing
Centogene, a life science company based in Germany that specializes in rare and neurodegenerative diseases, and Lifera, a biopharmaceutical company owned by the Public...
ACHEMA 2024: Shaping the future of the process industries
From 10 to 14 June 2024, ACHEMA will once again be the place to go for the entire range of technologies and services for...
New Guidelines: Medicare To Directly Negotiate Drug Prices
The Biden administration has issued new guidelines for its program that enables Medicare to directly negotiate drug prices with manufacturers. The updated guidelines provide...
Environmental Consciousness Rising In Global Healthcare
The global healthcare sector is increasingly embracing environmentally conscious practices, particularly in the pharmaceutical industry, which is prioritizing initiatives aligned with environmental, social, and...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...





















